<DOC>
	<DOCNO>NCT01120379</DOCNO>
	<brief_summary>XIENCE V USA prospective , multi-center , multi-cohort post-approval study . The objective study - To evaluate XIENCE V EECSS continue safety effectiveness commercial use real world setting , - To support Food Drug Administration ( FDA ) dual antiplatelet therapy ( DAPT ) initiative . This initiative design evaluate composite death , myocardial infarction ( MI ) stroke ( MACCE ) survival patient free Academic Research Consortium ( ARC ) definite probable stent thrombosis ( ST ) treat drug elute stent ( DES ) extend dual antiplatelet therapy .</brief_summary>
	<brief_title>XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study ( XIENCE V® USA Long Term Follow-up Cohort )</brief_title>
	<detailed_description>Among patient enrol XIENCE V USA complete Study Phase I , eligible participate XIENCE V USA Long Term Follow-up ( LTF ) Cohort . This LTF cohort prospective , open-label , multi-center , observational , single-arm study design evaluate XIENCE V EECSS continue safety effectiveness real world setting 1 year index procedure 5 year . The XIENCE V USA LTF cohort consist follow initial 5,000 patient : - The first 1,500 on-label patient treat accordance XIENCE V EECSS Instruction Use ( IFU ) , consecutively enrol XIENCE V USA study - The remain patient participate HCRI-DAPT cohort - Data monitoring committee two year</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Coronary Stenosis</mesh_term>
	<mesh_term>Coronary Restenosis</mesh_term>
	<mesh_term>Coronary Occlusion</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>The patient agree participate study sign Institutional Review Board approve inform consent form . The inability obtain informed consent . Age limit determine investigator . There angiographic inclusion exclusion criterion study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>drug elute stent</keyword>
	<keyword>Stents</keyword>
	<keyword>Angioplasty</keyword>
	<keyword>Stent thrombosis</keyword>
</DOC>